In vivo AND in vitro MODELS OF HEPATITIS B VIRUS INFECTION
Биохимия / Biochemistry · 2025 · 90 (11) · 1601
DOI: 10.7868/s3034529425110056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Биохимия / Biochemistry, 2025. Verfasst von Y.V. Kolyako und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Hepatitis B virus (HBV) is a hepatotropic virus from the Hepadnaviridae family and the causative agent of acute and chronic hepatitis B (CHB). The outcomes of HBV infection include liver cirrhosis and hepatocellular carcinoma (HCC), posing a significant burden on healthcare systems worldwide. In the nuclei of infected hepatocytes of patients with CHB, the HBV genome persists as a pool of covalently closed circular DNA (cccDNA) molecules. Current therapeutic strategies cannot directly target cccDNA. Instead, available treatments focus on long-term suppression of viral replication and require lifelong administration. The development and evaluation of novel antiviral agents capable of achieving complete HBV eradication require relevant in vivo and in vitro models of HBV infection. Among the available animal models, the following categories can be distinguished: (1) animals naturally susceptible to HBV; (2) surrogate models employing species susceptible to related hepadnaviruses; (3) non-susceptible animals receiving the HBV genome via recombinant viral vectors; (4) models utilizing human hepatocyte xenografts. Among the available in vitro models, primary human and treeshrew (Tupala) hepatocytes fully support the HBV replication cycle, but they rapidly lose susceptibility to the virus. In turn, human hepatoma cell lines are not directly susceptible to HBV, but support viral replication upon transfection with the viral genome. This review discusses the key characteristics, advantages, limitations and areas of application of currently available in vivo and in vitro models of HBV infection.
Zitieren
APA
Kolyako, Y., Zhitkevich, A., Avdoshina, D., Tanygina, D., Apolokhov, V., Gorodnicheva, T., Kostyushev, D., Bayurova, E., & Gordeychuk, I. (2025). In vivo AND in vitro MODELS OF HEPATITIS B VIRUS INFECTION. Биохимия / Biochemistry, 90(11), 1601. https://doi.org/10.7868/s3034529425110056
Vancouver
Kolyako Y, Zhitkevich A, Avdoshina D, Tanygina D, Apolokhov V, Gorodnicheva T, et al. In vivo AND in vitro MODELS OF HEPATITIS B VIRUS INFECTION. Биохимия / Biochemistry. 2025;90(11):1601. doi:10.7868/s3034529425110056
BibTeX
@article{Kolyako2025,
author = {Kolyako, Y.V. and Zhitkevich, A.S. and Avdoshina, D.V. and Tanygina, D.Y. and Apolokhov, V.D. and Gorodnicheva, T.V. and Kostyushev, D.S. and Bayurova, E.O. and Gordeychuk, I.V.},
title = {In vivo AND in vitro MODELS OF HEPATITIS B VIRUS INFECTION},
journal = {Биохимия / Biochemistry},
year = {2025},
volume = {90},
number = {11},
pages = {1601},
doi = {10.7868/s3034529425110056}
}
EUVIMED